Table 3.
Spearman correlation matrix for the variables included in the OPLS models
| BADDS Total | ASRS Total | WURS ADHD | GAF Symptom | GAF Function | CGI‐S | WAIS‐III FSIQ | Sex | Age | Comorbidity | Sickleave | Medication | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BADDS Total | ||||||||||||
| ASRS Total | 0.515** | |||||||||||
| WURS ADHD | 0.047 | 0.017 | ||||||||||
| GAF Symptom | ‐0.435** | −0.204 | 0.140 | |||||||||
| GAF Function | −0.287* | −0.027 | 0.129 | 0.707** | ||||||||
| CGI−S | 0.169 | −0.159 | 0.121 | −0.306* | −0.394** | |||||||
| WAIS‐III FSIQ | 0.215 | 0.009 | −0.565** | −0.169 | −0.001 | −0.081 | ||||||
| Female | −0.104 | −0.224 | −0.046 | 0.229 | 0.226 | −0.199 | 0.324 | |||||
| Age | 0.096 | 0.109 | −0.049 | −0.364** | −0.331* | −0.129 | 0.005 | 0.128 | ||||
| Comorbidity | 0.059 | −0.114 | −0.022 | −0.180 | −0.176 | 0.481** | −0.054 | −0.201 | 0.048 | |||
| Sick leave | 0.139 | −0.094 | 0.090 | −0.354* | −0.582** | 0.580** | −0.041 | −0.252 | 0.107 | 0.304 | ||
| Medication | 0.022 | 0.156 | −0.394** | −0.105 | −0.164 | −0.043 | 0.070 | −0.143 | 0.143 | 0.225 | −0.024 | |
| BADDS Total 5y | 0.661** | 0.272 | 0.170 | −0.337* | −0.235 | 0.035 | −0.053 | 0.039 | 0.224 | 0.086 | −0.014 | −0.011 |
| ASRS 5y | 0.523** | 0.452** | 0.170 | −0.242 | −0.061 | −0.010 | 0.044 | −0.004 | 0.205 | −0.002 | −0.139 | 0.108 |
| CGI−S 5y | 0.358* | 0.121 | 0.099 | −0.461** | −0.485** | 0.215 | 0.155 | −0.094 | 0.238 | 0.175 | 0.137 | 0.013 |
| GAF Function 5y | −0.233 | −0.037 | −0.119 | 0.274 | 0.435** | −0.093 | 0.027 | 0.050 | −0.076 | −0.089 | −0.126 | 0.098 |
**Correlation is significant at the 0.01‐level (2‐tailed); * Correlation is significant at the 0.05‐level (2‐tailed).
BADDS, Brown ADD Rating Scale; ASRS, The WHO Adult ADHD Self‐report Scale; CGI‐S, Clinical Global Impression‐Symptoms; GAF, Global Assessment of Functioning; WAIS, Wechsler Adult Intelligence Scale; FSIQ, Full Scale Intelligence Quotient.